Article Information
History
- May 23, 2020.
Article Versions
- Version 1 (January 22, 2019 - 16:20).
- Version 2 (February 15, 2019 - 18:03).
- Version 3 (July 18, 2019 - 02:55).
- Version 4 (August 11, 2019 - 13:25).
- Version 5 (January 9, 2020 - 02:03).
- You are currently viewing Version 6 of this article (May 23, 2020 - 00:18).
- Version 7 (June 8, 2021 - 07:09).
- View Version 8, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Biswajyoti Sahu1,2,3,
- Päivi Pihlajamaa1,3,
- Kaiyang Zhang4,
- Kimmo Palin1,2,
- Saija Ahonen1,2,
- Alejandra Cervera4,
- Ari Ristimäki1,2,5,
- Lauri A. Aaltonen1,2,
- Sampsa Hautaniemi4 and
- Jussi Taipale1,3,6,*
- 1Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Finland
- 2Medicum, Faculty of Medicine, University of Helsinki, Finland
- 3Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
- 4Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland
- 5Department of Pathology, HUSLAB, Helsinki University Hospital, University of Helsinki, Finland
- 6Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- ↵*Corresponding author: Jussi Taipale (ajt208{at}cam.ac.uk)
Posted May 23, 2020.
